menu
    • menu

    Company profile for ARS Pharmaceuticals

    NEW Drugs in Dev: 3
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our mission at ARS Pharmaceuticals is to provide at-risk patients and their families superior protection from severe allergic reactions. We are developing a product that patients and their caregivers can use without anxiety or hesitation, confident in both the product and the ability to administer it.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ARS PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3525 Del Mar Heights Road #855 San Diego, CA 92130
    Telephone
    Telephone
    +1 858-799-1840
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://ars-pharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/arspharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ars_pharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eurneffy 1 mg Nasal Spray Recommended For EU Approval
    Eurneffy 1 mg Nasal Spray Recommended For EU Approval

    02 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/02/3230226/0/en/EURneffy-1-mg-adrenaline-nasal-spray-Recommended-for-Approval-in-the-EU-for-Emergency-Treatment-of-Type-1-Allergic-Reactions-including-Anaphylaxis-in-Children-Weighing-15-kg-to-30-.html

    GLOBENEWSWIRE
    02 Feb 2026
    Share Share
    ARS Pharma TV Ad For Neffy Needled By FDA In Untitled Letter
    ARS Pharma TV Ad For Neffy Needled By FDA In Untitled Letter

    29 Jan 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/marketing/ars-pharma-tv-ad-epinephrine-nasal-spray-neffy-needled-fda-untitled-letter

    FIERCE PHARMA
    29 Jan 2026
    Share Share
    California K-12 Schools Qualify for Neffy Program
    California K-12 Schools Qualify for Neffy Program

    21 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/21/3222728/0/en/California-K-12-Schools-Now-Eligible-for-neffyinSchools-Program-Offering-Needle-Free-Epinephrine-at-No-Cost-for-Emergency-Use.html

    GLOBENEWSWIRE
    21 Jan 2026
    Share Share
    Neffy Nasal Spray Approved In China For Community Epinephrine
    Neffy Nasal Spray Approved In China For Community Epinephrine

    29 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/29/3210899/0/en/neffy-epinephrine-nasal-spray-Approved-in-China-as-the-First-and-Only-Community-Use-Epinephrine-Product-for-the-Treatment-of-Allergic-Reactions-anaphylaxis.html

    GLOBENEWSWIRE
    29 Dec 2025
    Share Share
    ARS Pharma To Attend Piper Sandler 37Th Healthcare Conference
    ARS Pharma To Attend Piper Sandler 37Th Healthcare Conference

    26 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/26/3195092/0/en/ARS-Pharmaceuticals-to-Participate-in-Piper-Sandler-37th-Annual-Healthcare-Conference.html

    GLOBENEWSWIRE
    26 Nov 2025
    Share Share
    ARS Pharma Introduces Get Neffy® Program For Severe Allergic
    ARS Pharma Introduces Get Neffy® Program For Severe Allergic

    04 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/04/3180299/0/en/ARS-Pharma-Launches-Get-neffy-on-Us-for-Patients-with-Severe-Allergic-Reactions-to-Improve-Access-to-neffy-epinephrine-nasal-spray.html

    GLOBENEWSWIRE
    04 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search